Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
Cancer Letters|April 29, 2022
Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancerSanaz Taromi, Elke Firat, Alexander Simonis, et al.
Blood Advances|June 6, 2020
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG miceVeronika Lysenko, Nicole Wildner-Verhey van Wijk, Kathrin Zimmermann, et al.
Cancer Letters|August 18, 2021
RETRACTED: Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancerSanaz Taromi, Elke Firat, Alexander Simonis, et al.
Cancer Letters|April 24, 2022
Retraction notice to "Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer" [Canc. Lett. 520 (2021) 385-399]Sanaz Taromi, Elke Firat, Alexander Simonis, et al.
British Journal of Haematology|November 16, 2022
Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantationAndriyana K Bankova, Chloé Pasin, Alice Huang, et al.
Nature Communications|January 22, 2019
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studiesYuanbin Song, Anthony Rongvaux, Ashley Taylor, et al.
Journal for Immunotherapy of Cancer|October 24, 2025
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistanceMarianna Ponzo, Lorenzo Drufuca, Chiara Buracchi, et al.
The Journal of Clinical Investigation|April 28, 2022
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody responseMaddalena Marconato, Irene A Abela, Anthony Hauser, et al.
Bioinformatics (Oxford, England)|October 3, 2017
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysisJochen Singer, Hans-Joachim Ruscheweyh, Ariane L Hofmann, et al.
Hemasphere|November 20, 2024
A single-chain variable fragment-based bispecific T-cell activating antibody against CD117 enables T-cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cellsLaura Volta, Renier Myburgh, Mara Hofstetter, et al.
Pageof 26